Antipodes Partners awarded

2026 Fund Manager of the Year, Australia

Morningstar Awards 2026 © Morningstar, Inc. All Rights Reserved.

Antipodes Emerging Markets Fund

Fund overview

The Antipodes Emerging Markets Fund is an actively managed long only equities fund focused on attractively valued companies exposed to emerging markets or listed on emerging market stock exchanges.

Our selective approach, typically holding a minimum of 30 long positions, combines rigorous research and disciplined stock selection to target long-term capital growth for investors willing to accept higher volatility.

This product is classified as a Hedge Fund under ASIC Regulatory Guide RG240 and may have complex features. This product is likely to be suitable for investors who have received personal advice.

Ratings

The Antipodes Emerging Markets Fund has been rated “Recommended” by Zenith Investment Partners and Lonsec Research.
 

Performance chart

Cumulative performance (over selected time horizon)

All returns are net of fees and in AUD terms. Calculations are based on exit price with distributions reinvested, after ongoing fees and expenses but excluding taxation. Past performance is not a reliable indicator of future performance. The inception date is the date that the current investment strategy was adopted (1 October 2022).

Net performance

wpDataTable with provided ID not found!
All returns are net of fees and in AUD terms. Past performance is not a reliable indicator of future performance. 1The inception date is the date that the current investment strategy was adopted (1 October 2022). 2MSCI Emerging Markets Index in AUD.

Key facts

1The portfolio allocation ranges provided are indicative only. The Fund will be rebalanced within a reasonable period of time should the exposure move outside these ranges.

Unit price history
Distribution history
Portfolio profile as at 31st October 2026
Top 10 equity longs (%)
Sector exposure (%)2
Regional exposure (%)1, 3
1 Where possible, regions, countries and currencies classified on a look through basis. 2 GICS Classification. 3 Antipodes Partners classification.
Monthly updates


For historical reports, please contact the Antipodes team

For historical reports, please contact the Antipodes team
Invest

If you are applying online, or using paper application forms, the minimum investment in the Antipodes Emerging Markets Fund is $25,000 for new investors and $5,000 for existing investors.


Who may invest in the fund

This fund is open to investors from Australia and New Zealand. For international investors, please visit our international page for investment options.

Online applications are available for individuals, partnerships, SMSFs, superannuation funds and other regulated trusts and companies. Applications for unregulated trusts, (such as family and testamentary trusts) cannot be completed online and should make use of the paper based application form in the ‘All forms’ section of this page.


Important information

It is a legal requirement to download and read the Product Disclosure Statement before proceeding and we recommend that you consult a licensed financial advisor before making investment decisions.

Download Product Disclosure Statement.

Download Target Market Determination (TMD).


Apply online

The application below allows you to open an account with our distribution partner; Pinnacle Investment Management Group Pty Ltd (‘Pinnacle’), who focus on providing superior investment services and delivering investment excellence.

  1. Select your account type
  2. Complete the application form, selecting the relevant fund
  3. Verify your identity online (use your Drivers Licence)
  4. Submit the application
  5. Separately make a secure payment from your bank account to the Trustee

Receive live email notifications as the application is processed.

Financial advisers:

Apply online

Individual investors:

Apply online

 

Apply via a paper form

Purchase, top-up or sell a managed fund investment the familiar way.

  1. Download an application form here
  2. Complete the application form & sign
  3. Provide certified copies of your identity to verify your identity
  4. Post original form and certified documents to:
    Antipodes Emerging Markets Fund
    C/ Citi Unit Registry Australia
    GPO 764
    MELBOURNE
    VIC 3001
  5. Separately make a secure payment from your bank account to the Trustee

Download an application form

Benefits of investing in the Antipodes Emerging Markets Fund

  • Regional exposure: Access a carefully selected portfolio of emerging market companies often unavailable to retail investors.
  • Professional management: Experienced team leveraging a disciplined investment process aimed at achieving absolute returns above the benchmark over a full market cycle.
  • Aligned interests: Antipodes is majority owned by its investment team with a performance culture underpinned by sensible incentives, ensuring our goals align with yours.
  • Robust investment process: Comprehensive, integrated investment approach and process.

Who is this fund for?

  • Investors seeking long-term capital growth via a diversified portfolio of emerging market equities.
  • Those comfortable with high or very high risk and minimum investment horizon of 5 years.
  • Investors looking to use the fund as a core, minor, or satellite allocation within a broader diversified portfolio.

Key fund information

Strategy

Emerging Markets

Strategy inception date

1 July 2015

Investment objective

The Fund aims to outperform the benchmark over the investment cycle (typically 3-5 years)

Benchmark

MSCI Emerging Market Index

Suggested minimum investment period

5 years

Minimum initial investment

A$25,000

Management fee

0.95% p.a. of the NAV of the Fund

Performance fee

15% of net return in excess of the benchmark

Frequently asked questions

What is an emerging market?

An emerging market is a country or economy that is transitioning from developing to developed status. These markets typically experience rapid economic growth, expanding industries, and improving financial systems. Investing in emerging markets provides access to companies with strong growth potential, often unavailable in developed markets, but can involve higher volatility and risk.

An emerging markets fund is an investment vehicle that focuses on companies in developing economies. These funds aim to provide higher growth potential than developed markets but can involve higher risk and volatility.

The “best” emerging markets fund varies depending on your investment goals, risk tolerance, and desired investment horizon. The Antipodes Emerging Markets Fund is a leading choice, offering a diversified portfolio of undervalued emerging market shares. Actively managed with a long-term growth focus, it aims to deliver superior returns while providing investors with access to opportunities often unavailable through passive funds or ETFs.

Distributions for the Antipodes Emerging Markets Fund are paid once a year, at the end of the financial year (30 June).

Important information

This webpage is prepared by Antipodes Partners Limited (‘Antipodes’) (ABN 29 602 042 035 , AFSL 481 580) as the investment manager of the Antipodes Emerging Markets Fund (ARSN 096 451 393) (the ‘Fund’). Pinnacle Fund Services Limited (‘PFSL’) (ABN 29 082 494 362, AFSL 238 371) is the product issuer of the Fund. PFSL is not licensed to provide financial product advice. PFSL is a wholly-owned subsidiary of the Pinnacle Investment Management Group Limited (‘Pinnacle’) (ABN 22 100 325 184) .

The information provided in this website is of a general nature only and has been prepared without taking into account your objectives, financial situation or needs. Before making an investment decision in respect of the Fund, you should consider the current Product Disclosure Statement (PDS) and Target Market Determination (‘TMD’) of the Fund and the Fund’s other periodic and continuous disclosure announcements lodged with the ASX, which are available at www.asx.com.au, and assess whether the Fund is appropriate given your objectives, financial situation or needs. If you require advice that takes into account your personal circumstances, you should consult a licensed or authorised financial adviser.

Neither PFSL nor Antipodes guarantees repayment of capital or any particular rate of return from the Fund. There can be no assurance that the Fund will achieve its investment objectives. The value of your units at any point in time may be worth less than your original investment even after taking into account the reinvestment of Fund distributions. Returns are not guaranteed, and you may lose some or all of your money. The specific risks associated with investing in the Fund, and the risks associated with the Fund’s investments, are discussed in Section 6 of the Product Disclosure Statement. Neither PFSL nor Antipodes gives any representation or warranty as to the currency, reliability, completeness or accuracy of the information contained in this website. All opinions and estimates included in this website constitute judgments of Antipodes as at the date of website creation and are subject to change without notice. Past performance is not a reliable indicator of future performance.

The Zenith Investment Partners (ABN 27 103 132 672, AFS Licence 226872) (“Zenith”) rating assigned  Antipodes Emerging Markets Fund (IOF0203AU) – October 2025 referred to in this piece is limited to “General Advice” (s766B Corporations Act 2001) for Wholesale clients only. This advice has been prepared without taking into account the objectives, financial situation or needs of any individual, including target markets of financial products, where applicable, and is subject to change at any time without prior notice. It is not a specific recommendation to purchase, sell or hold the relevant product(s). Investors should seek independent financial advice before making an investment decision and should consider the appropriateness of this advice in light of their own objectives, financial situation and needs. Investors should obtain a copy of, and consider the PDS or offer document before making any decision and refer to the full Zenith Product Assessment available on the Zenith website. Past performance is not an indication of future performance. Zenith usually charges the product issuer, fund manager or related party to conduct Product Assessments. Full details regarding Zenith’s methodology, ratings definitions and regulatory compliance are available on our Product Assessments and at Fund Research Regulatroy Guidelines.

The rating issued 25/03/2025 for the Antipodes Emerging Markets Fund (IOF0203AU)  is published by Lonsec Research Pty Ltd ABN 11 151 658 561 AFSL 421 445 (Lonsec). Ratings are general advice only, and have been prepared without taking account of your objectives, financial situation or needs. Consider your personal circumstances, read the product disclosure statement and seek independent financial advice before investing. The rating is not a recommendation to purchase, sell or hold any product. Past performance information is not indicative of future performance. Ratings are subject to change without notice and Lonsec assumes no obligation to update. Lonsec uses objective criteria and receives a fee from the Fund Manager. Visit lonsec.com.au for ratings information and to access the full report. © 2026 Lonsec. All rights reserved.

Now available on the ASX: the Antipodes Global SMID Active ETF (ASX:MIDS)

X